Immunohistochemistry analysis confirmed successful local SLC6A6 overexpression in vivo (Figure 7B), and qRT-PCR and Western blotting further confirmed that SLC6A6 mRNA and protein levels were increased in the AD-SLC6A6 group compared to controls (Figure 7C,D). Here, SLC6A6 is linked to Alzheimer disease.